Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2178)	6/23/2009 2:57:35 PM
From: tom pope	Respond to of 2240

Yeah, but your Mom doesn't have the prostate problems I may have!

To: tuck who wrote (2178)	6/23/2009 3:05:42 PM
From: scaram(o)uche	Respond to of 2240

I did not say that Lowe's analysis of medx was a cheap shot. But you are correct, he adds little.

To: tuck who wrote (2178)	6/23/2009 3:57:22 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2240

Here's an idea, Tuck. Since you contribute, on occasion, to his web page? Why not ask him to post a list of his publications? Ask him to detail the medicines to which his research has contributed? I think that you'll find that the vaunted 20 year career has led to less than a handful of first-author papers, all of which were published in candy-ass journals. If you can't do science, write about it. David Baltimore can go on a blog and be dismissive of the science of others. Derek Lowe, whoever TF he is, can't. The holes in his rationale are large, but not as large as his blog-reflected mouth.

To: tuck who wrote (2178)	6/24/2009 3:53:03 AM
From: scaram(o)uche	2 Recommendations Respond to of 2240

>> The PR is hype -- possibly justified, but too soon to say -- without the numbers to back it up. << The two patients were taken OFF PROTOCOL. The Mayo physicians are not describing results of a Medarex clinical trial, they are talking about two patients who elected to have surgery and thus to leave a physician-sponsored trial. The Mayo physicians are therefore talking about two of two, they have every right to do so, and there is absolutely NO reason that they shouldn't. It is difficult as heck to recruit naive prostate patients.... competition among sites is horrific. This research was supported by the Department of Defense, The Richard M. Schulze Family Foundation, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic Center for Translational Science Activities. Medarex Inc. provided the free study drug.